Bone Support with Strontium & Boron

Bone Support with Strontium & Boron

Dr. Mercola4.7 (275 ratings)
Format:Capsule Quantity: 60 Capsule(s) · 30 servings
Goals
$14.99 $0.49 per serving

Product analysis

61 out of 100

Bone Support with Strontium & Boron supplies minerals connected to bone metabolism, with uncertain routine bone-strength benefits. Strontium can increase a bone-scan reading without showing that bones are stronger.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality49

Manganese is the clearest form-quality strength. Silicon and boron offer weaker quality support, while comparative quality for strontium remains unresolved.

Ingredient Transparency88

Amounts and the principal mineral forms are stated. Some descriptions remain incomplete, limiting a fully consistent comparison across the formula.

Value For Money41

Silicon offers reasonably favorable value, while the boron contribution looks costly at the full serving price. Manganese offers middling value and strontium value remains unresolved.

Customer Satisfaction74

Customer ratings are favorable across several hundred reviews. Satisfaction is encouraging without establishing stronger bones or hormone effects.

Product Focus64

Bone support is the clearest purpose, but routine bone-density and fracture benefits are not established. Strontium can inflate bone-scan readings, so a higher result does not necessarily show stronger bone.

Format
Capsule
Container
60 Capsule(s)
Per serving
$0.49
Customer rating
4.7 · 275 ratings
Report analysis

Goals

Impact
High effect
B+ Ingredient FitC- PathwaysA- EvidenceA Formulation Logic
Manganese · 2 mgBoron · 3 mg

Boron and manganese have mineral-metabolism and matrix-related roles, but the supplied human evidence does not establish routine bone-density or fracture benefits. Strontium citrate cannot inherit prescription strontium-ranelate findings, and strontium can inflate DXA bone-density measurements without proving stronger bone. The saved result recognized calcium-regulation coverage, while silicon lacked a usable amount and did not meet its minimum criterion.

How this product is rated for Bone Health

Ingredient fit83

Boron, manganese and strontium form a focused selection, with silicon's amount unresolved.
Goal fit
Boron, manganese and strontium form a focused selection, with silicon's amount unresolved.
Dose adequacy
Amounts received partial recognition; silicon lacked a usable amount.

Pathways57

Calcium absorption and regulation was the strongest saved finding. Only calcium regulation reached the saved breadth criterion.
Depth
Calcium absorption and regulation was the strongest saved finding; this does not measure stronger bone.
Breadth
Only calcium regulation reached the saved breadth criterion.

Evidence85

Boron drove the saved evidence finding; the amount recognition does not establish extra bone-density or fracture benefit.
Evidence strength
Boron drove the saved evidence finding; the amount recognition does not establish extra bone-density or fracture benefit.
Studied preparation
Strontium lacked studied-preparation recognition.

Formulation logic94

No contributing ingredient lacked a required partner in the saved result. No listed conflict was matched.
Partner coverage
No contributing ingredient lacked a required partner in the saved result.
Conflicts
No listed ingredient conflict was matched in the saved result.
Effective doses
Silicon did not meet the saved minimum amount criterion.
Study evidence
Boron Supportive 5 studies
Manganese Adverse 12 studies
Silicon Supportive 13 studies
Strontium Not classified

No linked studies yet.

Everyday Health
Impact
Moderate effect
D+ Ingredient FitF PathwaysB+ EvidenceA+ Formulation Logic
Boron · 3 mg

Boron at 3 mg relates to bone and mineral metabolism, with manganese adding essential-nutrient context. The supplied boron findings come from limited studies in particular settings and do not establish a routine broad health benefit.

How this product is rated for Everyday Health

Ingredient fit55

The assessed contribution sits within a broader formula with other actives that add no independent contribution in these findings. The assessed amount provides partial coverage of the saved dose comparison.
Goal fit
The assessed contribution sits within a broader formula with other actives that add no independent contribution in these findings.
Dose adequacy
The assessed amount provides partial coverage of the saved dose comparison.

Pathways19

The strongest saved contribution concerns bone and mineral metabolism, with limited coverage. No assessed health process reaches the saved coverage threshold.
Depth
The strongest saved contribution concerns bone and mineral metabolism, with limited coverage.
Breadth
No assessed health process reaches the saved coverage threshold.

Evidence82

Boron provides the strongest saved evidence contribution at the assessed amount; its scope and limitations still apply. The ingredients meeting the saved amount threshold have preparations accepted by the saved evidence assessment.
Evidence strength
Boron provides the strongest saved evidence contribution at the assessed amount; its scope and limitations still apply.
Studied preparation
The ingredients meeting the saved amount threshold have preparations accepted by the saved evidence assessment.

Formulation logic100

The assessed ingredients can contribute independently or have their required companion present. No ingredient conflict was identified by the saved checks. All ingredients included in the saved dose check reach its minimum threshold.
Partner coverage
The assessed ingredients can contribute independently or have their required companion present.
Conflicts
No ingredient conflict was identified by the saved checks.
Effective doses
All ingredients included in the saved dose check reach its minimum threshold.
Study evidence
Boron Supportive 6 studies
Impact
Moderate effect
D+ Ingredient FitF PathwaysC EvidenceA+ Formulation Logic
Boron · 3 mg

Whether boron produces a lasting testosterone increase is unclear. Short-term hormone changes don't show a durable benefit, and other hormone results have not supported a consistent increase. The declared boron amount alone therefore gives little indication of what change, if any, you would notice.

How this product is rated for Testosterone Support

Ingredient fit51

Boron provides the relevant ingredient connection. Ingredient presence alone doesn't show that testosterone will rise.
Goal fit
Boron is relevant to this goal; other active ingredients don't automatically add a testosterone benefit.
Dose adequacy
The declared serving supplies Boron 3 mg. These amounts don't predict a testosterone increase.

Pathways15

Boron is linked to free-testosterone availability, but a lasting hormone benefit remains uncertain.
Depth
Boron is linked to free-testosterone availability, but a lasting hormone benefit remains uncertain.
Breadth
The ingredients do not imply broad hormone effects; nutrient-related benefits and direct testosterone increases are different outcomes.

Evidence63

Boron has uncertain lasting effects on testosterone.
Evidence strength
Boron has uncertain lasting effects on testosterone.
Studied preparation
The ingredient forms are compatible with their hormone-related context, but that does not guarantee a testosterone increase.

Formulation logic100

No particular ingredient conflict or required missing partner is identified. The ingredients can be considered individually without assuming an added hormone effect from combining them.
Partner coverage
The relevant ingredients do not require an additional partner ingredient for their individual roles.
Conflicts
No particular ingredient conflict is identified.
Effective doses
The relevant ingredient amounts are declared; reaching a comparison amount does not guarantee a hormone benefit.
Study evidence
Boron Disputed 3 studies

Ingredients

IngredientAmount per servingScore
Calories
5 Calorie(s)
Total Carbohydrates
1 Gram(s)
Manganese (Manganese Bisglycinate Chelate)
2 mg 84
Strontium (Strontium Citrate)
500 mg
Silica (Living Silica)
3 mg 37
Boron (Boron Amino Acid Chelate)
3 mg 63
Adults 18–50
Report overview
A+ Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyD+ Value
D- Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyF Value
F Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyB- Value
The serving lists 3 mg of silica, but its elemental silicon amount is unknown. The whole-product serving costs about $0.50.
How this ingredient is rated

Active Ingredient Quality & Bioavailability27

The named chemical form is silica. The saved evidence does not establish extract standardization.
Silicon Chemical Form & Absorption
The named chemical form is silica.
Botanical Standardization & Extract Quality
The saved information records no extract ratio or silica standardization percentage.
Trademark and Source Transparency
Silica is named, but a more specific source is not identified in the saved facts.

Dose, Safety & Label Transparency30

The serving lists 3 mg of silica; its elemental silicon amount is not established.
Elemental Silicon Dosage Adequacy
The serving lists 3 mg of silica; its elemental silicon amount is not established.
Label Transparency: Source vs. Active Yield
The 3 mg silica quantity is stated, but that is not an elemental silicon amount.

Value70

The whole-product serving costs about $0.50, a moderate price in this comparison.
Price per Serving Relative to Median
The whole-product serving costs about $0.50, a moderate price in this comparison.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. [Comparative study of the urinary excretion of boron, calcium, magnesium and phosphorus in postmenopausal women with and without osteoporosis].
    José Ramón V; Mora Mora M; Marino Alarcón O; Hernández G; Josefina Linares L; Urdaneta Romero H; Arévalo González E · Investigacion clinica · 2013
    Case-control study45 participantsBone Health forBoron
  2. Effect of dietary boron on mineral, estrogen, and testosterone metabolism in postmenopausal women.
    Nielsen FH; Hunt CD; Mullen LM; Hunt JR · FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 1987
    Single-arm trial12 participantsBone Health forBoron
  3. The relationship between boron and magnesium status and bone mineral density in the human: a review.
    Volpe SL; Taper LJ; Meacham S · Magnesium research · 1994
    Narrative reviewBone Health forBoron
  4. Effects of boron supplementation on bone mineral density and dietary, blood, and urinary calcium, phosphorus, magnesium, and boron in female athletes.
    Meacham SL; Taper LJ; Volpe SL · Environmental health perspectives · 1995
    Randomized trial28 participantsBone Health forBoron
  5. Metabolic responses of postmenopausal women to supplemental dietary boron and aluminum during usual and low magnesium intake: boron, calcium, and magnesium absorption and retention and blood mineral concentrations
    C D Hunt, J L Herbel, F H Nielsen · The American Journal of Clinical Nutrition · 1997
    Non-randomized trial11 participantsBone Health forBoron
  6. Risk of Environmental Chemicals on Bone Fractures Is Independent of Low Bone Mass in US Adults: Insights from 2017 to 2018 NHANES.
    Ling R; Ai Y; Chen C; Zhang J; Zou Z; Cheng S; Li C; Li X; Wang B · Metabolites · 2023
    Cross-sectional study2,640 participantsBone Health forManganese
  7. The Manganese-Bone Connection: Investigating the Role of Manganese in Bone Health.
    Taskozhina G; Batyrova G; Umarova G; Issanguzhina Z; Kereyeva N · Journal of clinical medicine · 2024
    Narrative reviewBone Health forManganese
  8. Associations of multiple metals with bone mineral density: A population-based study in US adults.
    Wei MH; Cui Y; Zhou HL; Song WJ; Di DS; Zhang RY; Huang Q; Liu JA; Wang Q · Chemosphere · 2021
    Cross-sectional studyBone Health forManganese
  9. Sex-specific associations of urinary mixed-metal concentrations with femoral bone mineral density among older people: an NHANES (2017-2020) analysis.
    Li H; Li G; Yi M; Zhou J; Deng Y; Huang Y; He S; Meng X; Liu L · Frontiers in public health · 2024
    Cross-sectional study31 participantsBone Health forManganese
  10. Relationship between blood manganese and bone mineral density and bone mineral content in adults: A population-based cross-sectional study.
    Wang C; Zhu Y; Long H; Ou M; Zhao S · PloS one · 2022
    Cross-sectional study9,732 participantsBone Health forManganese
  11. The effect of choline-stabilized orthosilicic acid in patients with peri-implantitis: an exploratory randomized, double-blind, placebo controlled study.
    Teughels W; Celik GU; Tarce M; De Cock I; Persyn SM; Haytac MC · BMC oral health · 2021
    Randomized trial21 participantsBone Health forSilicon
  12. Calcium Phosphate Modified with Silicon vs. Bovine Hydroxyapatite for Alveolar Ridge Preservation: Densitometric Evaluation, Morphological Changes and Histomorphometric Study.
    Cadenas-Vacas G; Martínez-Rodríguez N; Barona-Dorado C; Sánchez-Labrador L; Cortés-Bretón Brinkmann J; Meniz-García C; Martínez-González JM · Materials (Basel, Switzerland) · 2021
    Non-randomized trialBone Health forSilicon
  13. Silicon: a review of its potential role in the prevention and treatment of postmenopausal osteoporosis.
    Price CT; Koval KJ; Langford JR · International journal of endocrinology · 2013
    Narrative reviewBone Health forSilicon
  14. Osteogenic Effect of a Bioactive Calcium Alkali Phosphate Bone Substitute in Humans.
    Knabe C; Adel-Khattab D; Rezk M; Cheng J; Berger G; Gildenhaar R; Wilbig J; Günster J; Rack A; Heiland M; Knauf T; Stiller M · Bioengineering (Basel, Switzerland) · 2023
    Clinical trial38 participantsBone Health forSilicon
  15. Silicon and bone health.
    Jugdaohsingh R · The journal of nutrition, health & aging · 2007
    Narrative reviewBone Health forSilicon
  16. Effects of boron supplementation on the severity and duration of pain in primary dysmenorrhea.
    Nikkhah S; Dolatian M; Naghii MR; Zaeri F; Taheri SM · Complementary therapies in clinical practice · 2015
    Randomized trial113 participantsEveryday Health forBoron
  17. Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies.
    Elewski BE; Aly R; Baldwin SL; González Soto RF; Rich P; Weisfeld M; Wiltz H; Zane LT; Pollak R · Journal of the American Academy of Dermatology · 2015
    Randomized trialEveryday Health forBoron
  18. The efficacy and safety of tavaborole, a novel, boron-based pharmaceutical agent: phase 2 studies conducted for the topical treatment of toenail onychomycosis.
    Toledo-Bahena ME; Bucko A; Ocampo-Candiani J; Herz-Ruelas ME; Jones TM; Jarratt MT; Pollak RA; Zane LT · Journal of drugs in dermatology : JDD · 2015
    Clinical trial336 participantsEveryday Health forBoron
  19. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
    Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT; Swedish Brain Tumour Study Group · Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2009
    Single-arm trial30 participantsEveryday Health forBoron
  20. Effects of Calcium Fructoborate on Levels of C-Reactive Protein, Total Cholesterol, Low-Density Lipoprotein, Triglycerides, IL-1β, IL-6, and MCP-1: a Double-blind, Placebo-controlled Clinical Study
    Otilia-Constantina Rogoveanu, George Dan Mogosanu, Cornelia Bejenaru, Ludovic Everard Bejenaru, Octavian Croitoru, Johny Neamtu, Zbigniew Pietrzkowski, Tania Reyes-Izquierdo, Andrei Bita, Iulia Daria Scorei, Romulus Ion Scorei · Biological Trace Element Research · 2015
    Randomized trial78 participantsEveryday Health forBoron